Methods and apparatus for synthesizing imaging agents, and intermediates thereof

Patent metadata

Field	Value
Publication number	US-8936777-B2
Application number	US-201113577674-A
Country	US
Kind code	B2
Filing date	Feb 8, 2011
Priority date	Feb 8, 2010
Publication date	Jan 20, 2015
Grant date	Jan 20, 2015

Abstract

The present invention generally relates to methods and system for the synthesis of imaging agents, and precursors thereof. The methods may exhibit improved yields and may allow for the large-scale synthesis of imaging agents, including imaging agents comprising a radioisotope (e.g., 18F). Various embodiments of the invention may be useful as sensors, diagnostic tools, and the like. In some cases, methods for evaluating perfusion, including myocardial perfusion, are provided. Synthetic methods of the invention have also been incorporated into an automated synthesis unit to prepare and purify imaging agents that comprise a radioisotope. In some embodiments, the present invention provides a novel methods and systems comprising imaging agent 1, including methods of imaging in a subject comprising administering a composition comprising imaging agent 1 to a subject by injection, infusion, or any other known method, and imaging the area of the subject wherein the event of interest is located.

First claim

What is claimed:

1. A method of synthesizing an imaging agent comprising the formula:

wherein:
W is alkyl or heteroalkyl, optionally substituted;
R 1 is alkyl, optionally substituted;
R 2 is hydrogen or halide;
each R 3 can be the same or different and is alkyl optionally substituted with an imaging moiety or heteroalkyl optionally substituted with an imaging moiety; and
n is 1, 2, 3, 4, or 5;

the method comprising steps of:
reacting precursor compounds comprising the formulae:

wherein:
n is 1, 2, 3, 4, or 5;
R 1 is alkyl, optionally substituted;
R 2 is hydrogen or halide;
R 3 can be the same or different and are alkyl, heteroalkyl, or a carbonyl-containing group, each optionally substituted;
R 5 is hydroxyl or halide; and
R 6 is alkyl, heteroalkyl, or a carbonyl-containing group, each optionally substituted;
wherein, when R 5 is hydroxyl, at least one of R 6 and R 3 comprises a leaving group;

or wherein R 5 is halide, at least one of R 6 or R 3 comprises a hydroxyl, to produce a compound comprising the formula:

wherein:
W is alkyl or heteroalkyl, optionally substituted;
R 1 is alkyl, optionally substituted;
R 2 is hydrogen or halide;
each R 3 can be the same or different and is alkyl optionally substituted with hydroxyl or heteroalkyl optionally substituted with hydroxyl; wherein at least one R 3 comprises hydroxyl; and
n is 1, 2, 3, 4, or 5;

reacting a compound comprising the formula:

wherein:
W is alkyl or heteroalkyl, optionally substituted;
R 1 is alkyl, optionally substituted;
R 2 is hydrogen or halide;
each R 3 can be the same or different and is alkyl optionally substituted with hydroxyl or heteroalkyl optionally substituted with hydroxyl; wherein at least one R 3 comprises hydroxyl; and
n is 1, 2, 3, 4, or 5;
with a sulfonate-containing species to produce a sulfonate-containing compound comprising the formula:

wherein:
W is alkyl or heteroalkyl, optionally substituted;
R 1 is alkyl, optionally substituted;
R 2 is hydrogen or halide;
each R 3 can be the same or different and is alkyl optionally substituted with a sulfonate-containing group or heteroalkyl optionally substituted with a sulfonate-containing group; wherein at least one R 3 comprises a sulfonate-containing group; and
n is 1, 2, 3, 4, or 5;

replacing the sulfonate-containing group of the sulfonate-containing compound with an imaging moiety in the presence of a bicarbonate salt to yield an imaging agent comprising the formula:

wherein:
W is alkyl or heteroalkyl, optionally substituted;
R 1 is alkyl, optionally substituted;
R 2 is hydrogen or halide;
each R 3 can be the same or different and is alkyl optionally substituted with an imaging moiety or heteroalkyl optionally substituted with an imaging moiety; and
n is 1, 2, 3, 4, or 5; provided that at least one imaging moiety is present in the imaging agent.

2. A method of synthesizing a product comprising an 18 F-species, comprising reacting a compound comprising the formula:

wherein:
R 1 is alkyl;
R 2 is hydrogen or halogen; and
R 3 is alkyl substituted with a sulfonate-containing group, alkoxy substituted with a sulfonate-containing group, or alkoxyalkyl substituted with a sulfonate-containing group; with an 18 F-containing species in the presence of a bicarbonate salt to form the product comprising the 18 F-species.

3. The method of claim 2 , wherein the sulfonate-containing group is mesylate, tosylate, triflate, or 1,2-cyclic sulfate.

4. The method of claim 2 , wherein R 1 is a methyl, ethyl, propyl, i-propyl, n-butyl, i-butyl, s-butyl, or t-butyl.

5. The method of claim 2 , wherein the product comprises the formula:

6. A method of synthesizing an imaging agent precursor comprising:
reacting a compound comprising formula (III):

wherein:
W is alkyl or heteroalkyl, optionally substituted;
R 1 is alkyl, optionally substituted;
R 2 is hydrogen or halide;
each R 3 can be the same or different and is alkyl optionally substituted with a leaving group or heteroalkyl optionally substituted with a leaving group; and
n is 1, 2, 3, 4, or 5;
provided at least one R 3 is substituted with a leaving group;

with a nucleophile, wherein the nucleophile replaces the leaving group to produce the imaging agent precursor.

7. A method of claim 6 , wherein reacting the compound with the nucleophile occurs in the presence of a base.

8. A method of claim 7 , wherein the base is a metal or metal salt.

9. A method of claim 6 , wherein reacting the compound with the nucleophile occurs in the presence of a catalyst.

10. A method of claim 9 , wherein the catalyst is a tetraalkylammonium iodide.

11. A method of claim 6 , wherein:
W is —O(CH 2 )—;
R 1 is t-butyl;
R 2 is chloride; and
R 3 is alkyl substituted with a leaving group.

12. A method of synthesizing an imaging agent, comprising:
contacting an imaging agent precursor with a fluoride species and a bicarbonate salt under conditions that result in the fluoride species replacing the leaving group to produce an imaging agent comprising the fluoride species,
wherein the molar ratio of bicarbonate salt to imaging agent precursor is less than about 1.5:1.

13. A method of manufacturing an imaging agent comprising the formula:

wherein the method comprises,
(a) contacting a tosylate precursor comprising the structure:

with a fluoride species associated with an ammonium salt in the presence of a bicarbonate salt;
(b) heating the mixture of (a);
(c) cooling the heated mixture;
(d) adding H 2 O to the cooled mixture;
(e) purifying the mixture from the hydrated mixture of (d) using HPLC with an H 2 O/MeCN eluent; and
(f) diluting the eluent with a solution of ascorbic acid or a salt thereof.

14. A method of synthesizing a fluorinated compound comprising 18 F, comprising:
reacting, in the presence of a bicarbonate salt, (i) a precursor of the fluorinated compound comprising an alkoxyalkyl group substituted with a halide or a sulfonate-containing group, with (ii) a salt comprising a fluoride species and weakly coordinating cation, wherein the fluoride species is enriched in 18 F.

15. A method of synthesizing a product comprising an 18 F-species, comprising reacting a compound comprising the formula:

Assignees

• Cesati Richard R
• Cheesman Edward H
• Lazewatsky Joel
• Radeke Heike S
• Mongeau Enrico
• Zdankiewicz Dianne D
• Devine Marybeth
• Lantheus Medical Imaging Inc

Inventors

• Cesati Richard R
• Cheesman Edward H
• Lazewatsky Joel
• Radeke Heike S
• Mongeau Enrico
• Zdankiewicz Dianne D
• Devine Marybeth

Classifications

• C07D237/16 Primary

  Two oxygen atoms · CPC title

• C07D237/14

  Oxygen atoms · CPC title

• C07D405/12

  linked by a chain containing hetero atoms as chain links · CPC title

• A61K51/0459 Primary

  having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine · CPC title

• C07D407/12

  linked by a chain containing hetero atoms as chain links · CPC title